This website uses cookies

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.

Some cookies on this site are essential, and the site won't work as expected without them. These cookies are set when you submit a form, login or interact with the site by doing something that goes beyond clicking on simple links.

We also use some non-essential cookies to anonymously track visitors or enhance your experience of the site. If you're not happy with this, we won't set these cookies but some nice features of the site may be unavailable.

Dear Patients,

On this website we would like to inform you about the phase III clinical trial COMPETE for treatment of neuroendocrine tumors of gastroenteric or pancreatic origin (GEP-NET). Please be aware, your attending doctor and a respective trial center need to confirm your participation in the study.


What are Clinical Trials?

Clinical trials play an important role in the development of new treatment opportunities. Patients can decide voluntarily to take part in them. The studies are subject to a strict quality control plan ...

View details >>


The phase III clinical trial COMPETE is led as an international, prospective, randomized, controlled, open-label, multicenter (in several countries at the same time) phase III study to evaluate the efficacy and safety ...

View details >>

What is Targeted Radionuclide Therapy?

The principle of radiation therapy against cancer is more than one hundred years old. In 1895, the discovery of a “new kind of radiation” and the opportunity of looking inside the body ...

View details >>